Does Entyvio Pen perform as well as Entyvio (infusion)?
Entyvio Pen is a self-injectable version of the same medicine as Entyvio (vedolizumab). Based on how it’s designed and used in treatment, the goal is to deliver the same drug (vedolizumab) and achieve similar outcomes in people with inflammatory bowel disease (ulcerative colitis or Crohn’s disease).
What evidence compares the pen vs the IV?
Comparisons typically focus on whether vedolizumab given by the pen achieves similar blood levels and similar response rates to vedolizumab given by infusion. If a trial or study shows comparable effectiveness between the two delivery methods, that supports “works as well” in real-world terms like symptom control and remission rates.
How dosing and timing can affect results
Even when the medicine is the same, delivery method can change the practical experience:
- Infusion schedules start in a clinic and follow a specific induction pattern.
- Pen use follows its own administration workflow, which may affect adherence and convenience.
If you miss doses or delay injections, outcomes can differ regardless of whether you use pen or IV.
Which patients usually choose the pen vs staying on IV?
The pen often appeals to people who want at-home dosing and fewer clinic visits. IV treatment may still be preferred if you:
- Need to start with infusion-based induction under clinician supervision
- Have difficulty with self-injection
- Have logistical or insurance constraints
The side-effect profile: same drug, similar expectations
Because Entyvio Pen and IV both deliver vedolizumab, the expected side effects and safety considerations are usually driven by the drug itself rather than the needle type. In practice, what changes most is where and how the medicine is administered.
Bottom line
Entyvio Pen is intended to work the same as Entyvio IV because it delivers the same medication (vedolizumab), just by a different route. The key practical question for your own care is whether you’re using it on the correct schedule and whether your clinician considers you a good fit for switching from IV to pen.
If you tell me whether you’re asking about ulcerative colitis or Crohn’s disease, and whether you’re switching from IV to pen or starting treatment, I can tailor the answer to what matters most for that situation.